MRgFUS is an advanced incisionless therapeutic technology mainly for treating movement disorders (e.g. Essential tremor, Parkinson's disease, dystonia) and even for psychiatric and oncological conditions. It is becoming a popular alternative to medication and surgical intervention for many medication-refractory conditions. The Hospital Authority is the first in Hong Kong to introduce this highly specialized service which will be available in the fourth quarter of 2024.
The COC of Neurosurgery has devised a tailored service model to ensure continuity of care and equity of patients' access to this treatment while matching the unique manpower distribution in Hong Kong.
With the completion of the new operating theatre extension block in Tuen Mun Hospital, the novel MRI guided Focused Ultrasound machine (Exablate Neuro 4000, Insightec) will be installed within the intraoperative MRI suite. Being one of the state of the art treatment modalities available in New Territory West Cluster (NTWC) neuroscience center, it will benefit patients with movement disorders who are refractory to medical treatment and unsuitable for invasive intervention.
